Ophthalmic research panel is a predesigned panel for detecting mutations in genes which associated with eye diseases. This panel contains a total of 317 genes. CD Genomics utilizes targeted NGS sequencing technology to provide more efficient and accurate targeting of specific genes or mutations, and even to detect low frequency variations. Targeted NGS sequencing facilitates sequencing of a large number of genes and samples in a single and cost-effective assay.
(Check the Ophthalmic Panel Sequencing Gene List for more genes.)
We provide customized bioinformatics analysis including:
CD Genomics provides the accurate and cost-effective ophthalmic panel sequencing and bioinformatics analysis. Our professional expert team executes quality management, following every procedure to ensure confident and unbiased results. The general workflow for ophthalmic panel sequencing is outlined below.
For more information about the ophthalmic panel or need other amplification requirements, please contact us.